Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (201-210 of 357) with videos related to

Pageof 36
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
In vitro thymidine labelling index in primary operable breast cancerS Holt, R Croton, S J Leinster, et al.
Advances in Anatomic Pathology|October 8, 2005
Clinical value of epidermal growth factor receptor expression in primary breast cancerR S Rampaul, S E Pinder, R I Nicholson, et al.
Endocrine-Related Cancer|January 30, 2007
Growth factor receptor interplay and resistance in cancerHelen E Jones, Julia M W Gee, Iain R Hutcheson, et al.
Breast Cancer Research and Treatment|January 1, 1992
Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyJ F Robertson, A R Dixon, R I Nicholson, et al.
Journal of Steroid Biochemistry|November 1, 1985
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerR I Nicholson, K J Walker, A Turkes, et al.
Endocrine-Related Cancer|August 1, 2013
Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab responseGlorianne Lazaro, Chris Smith, Lindy Goddard, et al.
International Journal of Cancer|August 5, 2005
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylationStephen Hiscox, Wen Go Jiang, Kathrin Obermeier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal womenP C Willsher, J F Robertson, N C Armitage, et al.
The Prostate|September 11, 2001
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathwaysH E Jones, D Barrow, C M Dutkowski, et al.
Breast Cancer Research and Treatment|September 29, 2007
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistanceJanice M Knowlden, Helen E Jones, Denise Barrow, et al.
Pageof 36

Showing results (201-210 of 357) with videos related to

Sort By:
Pageof 36
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
In vitro thymidine labelling index in primary operable breast cancerS Holt, R Croton, S J Leinster, et al.
Advances in Anatomic Pathology|October 8, 2005
Clinical value of epidermal growth factor receptor expression in primary breast cancerR S Rampaul, S E Pinder, R I Nicholson, et al.
Endocrine-Related Cancer|January 30, 2007
Growth factor receptor interplay and resistance in cancerHelen E Jones, Julia M W Gee, Iain R Hutcheson, et al.
Breast Cancer Research and Treatment|January 1, 1992
Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyJ F Robertson, A R Dixon, R I Nicholson, et al.
Journal of Steroid Biochemistry|November 1, 1985
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerR I Nicholson, K J Walker, A Turkes, et al.
Endocrine-Related Cancer|August 1, 2013
Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab responseGlorianne Lazaro, Chris Smith, Lindy Goddard, et al.
International Journal of Cancer|August 5, 2005
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylationStephen Hiscox, Wen Go Jiang, Kathrin Obermeier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal womenP C Willsher, J F Robertson, N C Armitage, et al.
The Prostate|September 11, 2001
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathwaysH E Jones, D Barrow, C M Dutkowski, et al.
Breast Cancer Research and Treatment|September 29, 2007
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistanceJanice M Knowlden, Helen E Jones, Denise Barrow, et al.
Pageof 36